Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
IL-33 delivery induces serous cavity macrophage proliferation independent of interleukin-4 receptor alpha. / Jackson-Jones, Lucy H; Rückerl, Dominik; Svedberg, Freya et al.
In: European Journal of Immunology, Vol. 46, No. 10, 10.2016, p. 2311-2321.Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - IL-33 delivery induces serous cavity macrophage proliferation independent of interleukin-4 receptor alpha
AU - Jackson-Jones, Lucy H
AU - Rückerl, Dominik
AU - Svedberg, Freya
AU - Duncan, Sheelagh
AU - Maizels, Rick M
AU - Sutherland, Tara E
AU - Jenkins, Stephen J
AU - McSorley, Henry J
AU - Bénézech, Cécile
AU - MacDonald, Andrew S
AU - Allen, Judith E
N1 - © 2016 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2016/10
Y1 - 2016/10
N2 - IL-33 plays an important role in the initiation of type-2 immune responses, as well as the enhancement of type 2 effector functions. Engagement of the IL-33 receptor on macrophages facilitates polarization to an alternative activation state by amplifying IL-4 and IL-13 signaling to IL-4Rα. IL-4 and IL-13 also induce macrophage proliferation but IL-33 involvement in this process has not been rigorously evaluated. As expected, in vivo delivery of IL-33 induced IL-4Rα-dependent alternative macrophage activation in the serous cavities. IL-33 delivery also induced macrophages to proliferate but, unexpectedly, this was independent of IL-4Rα signaling. In a filarial nematode infection model in which IL-4Rα-dependent alternative activation and proliferation in the pleural cavity is well described, IL-33R was essential for alternative activation but not macrophage proliferation. Similarly, during Alternaria alternata induced airway inflammation, which provokes strong IL-33 responses, we observed that both IL-4Rα and IL-33R were required for alternative activation, while macrophage proliferation in the pleural cavity was still evident in the absence of either receptor alone. Our data show that IL-33R and IL-4Rα promote macrophage proliferation independently of each other, but both are essential for induction of alternative activation.
AB - IL-33 plays an important role in the initiation of type-2 immune responses, as well as the enhancement of type 2 effector functions. Engagement of the IL-33 receptor on macrophages facilitates polarization to an alternative activation state by amplifying IL-4 and IL-13 signaling to IL-4Rα. IL-4 and IL-13 also induce macrophage proliferation but IL-33 involvement in this process has not been rigorously evaluated. As expected, in vivo delivery of IL-33 induced IL-4Rα-dependent alternative macrophage activation in the serous cavities. IL-33 delivery also induced macrophages to proliferate but, unexpectedly, this was independent of IL-4Rα signaling. In a filarial nematode infection model in which IL-4Rα-dependent alternative activation and proliferation in the pleural cavity is well described, IL-33R was essential for alternative activation but not macrophage proliferation. Similarly, during Alternaria alternata induced airway inflammation, which provokes strong IL-33 responses, we observed that both IL-4Rα and IL-33R were required for alternative activation, while macrophage proliferation in the pleural cavity was still evident in the absence of either receptor alone. Our data show that IL-33R and IL-4Rα promote macrophage proliferation independently of each other, but both are essential for induction of alternative activation.
KW - Alternaria
KW - Alternariosis
KW - Animals
KW - Cell Proliferation
KW - Cells, Cultured
KW - Filariasis
KW - Filarioidea
KW - Interleukin-1 Receptor-Like 1 Protein
KW - Interleukin-33
KW - Macrophage Activation
KW - Macrophages
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Knockout
KW - Pleural Cavity
KW - Receptors, Cell Surface
KW - Serous Membrane
KW - Signal Transduction
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1002/eji.201646442
DO - 10.1002/eji.201646442
M3 - Journal article
C2 - 27592711
VL - 46
SP - 2311
EP - 2321
JO - European Journal of Immunology
JF - European Journal of Immunology
SN - 0014-2980
IS - 10
ER -